Global Botulinum Toxin and HA Dermal Filler Market Report: Insights, Trends and Forecast (2019-2023)
- Koncept Analytics
- July 2019
- 132 pages
The global botulinum toxin & HA dermal filler market is estimated to reach US$11.06 billion in 2023, growing at a CAGR of 7.52%, for the period spanning from 2018 to 2023. The factors such as increasing urban population, growing ageing population, rising female workforce, escalating personal disposable income, evolving personal healthcare expenditure and growing number of plastic surgery and dermatology clinics are expected to drive the market growth. However, growth of the industry would be challenged by stringent regulations, patient health-associated risk and limited access to patent rights. A few notable trends include accelerating pharmaceutical R&D spending, progressing botulinum toxin products pipeline, rising minimally invasive procedures and growing preference for combination therapy.
Presently, botulinum toxin and HA dermal filler are widely used in therapeutics and aesthetics procedures for various purposes. Demand for these products was higher in therapeutic sector due to increasing approval of these injectables to manage nerve and muscular spasticity disorders by medicinal authorities.
The fastest growing regional market is North America owing to increasing geriatric population and rising demand for non-invasive aesthetic procedures in the US and Canada. The US is the largest market of botulinum toxin and HA dermal fillers and is already well-penetrated at developed market levels.
Scope of the report:
- The report provides a comprehensive analysis of the global botulinum toxin and HA dermal filler market, segmented on the basis of applications i.e. therapeutics and aesthetics.
- The major regional markets (North America, Europe and Asia-Pacific) have been analysed, along with country coverage of the U.S, Germany, Japan, Korea and China.
- The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
- The competitive landscape of the market, along with the company profiles of leading players (Allergan, Ipsen, Merz Pharma, Daewoong Pharmaceuticals, Medytox and Shanghai Haohai) are also presented in detail.
Key Target Audience:
- Botulinum Toxin and HA Dermal Filler Manufacturers
- Raw Material/Component Suppliers
- End Users (Hospitals & Clinics)
- Consulting Firms
- Investment Banks
- Government Bodies & Regulating Authorities
Have query on this report?Make an Enquiry
Table of Content
1. Market Overview
1.2 Botulinum Toxin
1.3 HA Dermal Fillers
2. Global Aesthetics Market Analysis
2.1 Global Aesthetic Market Value Forecast
2.2 Global Aesthetic Procedure Volume
2.3 Global Aesthetic Procedure Volume Forecast
2.4 Global Aesthetic Procedures by Types
3. Global Botulinum Toxin & HA Dermal Filler Market Analysis
3.1 Global Botulinum Toxin Market Value
3.2 Global Botulinum Toxin Market Value Forecast
3.3 Global Botulinum Toxin Market Value by Application
3.3.1 Global Therapeutics Botulinum Toxin Market Value
3.3.2 Global Therapeutics Botulinum Toxin Market Value Forecast
3.3.3 Global Aesthetics Botulinum Toxin Market Value
3.3.4 Global Aesthetics Botulinum Toxin Market Value Forecast
3.4 Global Aesthetics Botulinum Toxin Procedures
3.5 Global Aesthetics Botulinum Toxin Procedures Forecast
3.6 Global Aesthetics Botulinum Toxin Procedures by Country
3.7 Global Botulinum Toxin Market Value by Region
3.8 Global Dermal Filler Market Value Forecast
3.9 Global Aesthetic Dermal Filler Procedures by Types
3.10 Global HA Dermal Filler Market Value
3.11 Global HA Dermal Filler Market Value Forecast
3.12 Global HA Dermal Filler Procedures
3.13 Global HA Dermal Filler Procedures Forecast
3.14 Global HA Dermal Filler Procedures by Country
4. Regional Botulinum Toxin & HA Dermal Filler Market Analysis
4.1 North America
4.1.1 North America Botulinum Toxin Market Value Forecast
4.1.2 The U.S. Botulinum Toxin Market Value
4.1.3 The U.S. Botulinum Toxin Market Value Forecast
4.1.4 The U.S. Botulinum Toxin Market Value by Application
4.1.5 The U.S. Therapeutics Botulinum Toxin Market Value
4.1.6 The U.S. Therapeutics Botulinum Toxin Market Value Forecast
4.1.7 The U.S. Aesthetics Botulinum Toxin Market Value
4.1.8 The U.S. Aesthetics Botulinum Toxin Market Value Forecast
4.1.9 The U.S. Aesthetics Botulinum Toxin Procedures Forecast
4.1.10 The U.S. HA Dermal Filler Procedures Forecast
4.2.1 Europe Botulinum Toxin Market Value
4.2.2 Europe Botulinum Toxin Market Value Forecast
4.2.3 Europe Botulinum Toxin Market Value by Applications
4.2.4 Europe Therapeutics Botulinum Toxin Market Value
4.2.5 Europe Therapeutics Botulinum Toxin Market Value Forecast
4.2.6 Europe Aesthetics Botulinum Toxin Market Value
4.2.7 Europe Aesthetics Botulinum Toxin Market Value Forecast
4.2.8 Germany HA Dermal Filler Procedures Forecast
4.3.1 Asia-Pacific Botulinum Toxin Market Value Forecast
4.3.2 Japan Botulinum Toxin Market Value
4.3.3 Japan Botulinum Toxin Market Value Forecast
4.3.4 Korea Botulinum Toxin Market Value
4.3.5 Korea Botulinum Toxin Market Value Forecast
4.3.6 Korea Aesthetic Botulinum Toxin Market Volume Forecast
4.3.7 Korea HA Dermal Filler Market Value
4.3.8 Korea HA Dermal Filler Market Value Forecast
4.3.9 China HA Dermal Filler Market Value
4.3.10 China HA Dermal Filler Market Value Forecast
Botulinum Toxin-A Major Product Description
Upcoming Botulinum Toxin Product Launch by Region (2019-2023)
Key Players – Revenue Comparison (2018)
Key Players – Global Botulinum Toxin Product Feature Comparison (2018)
Key Players – Regional Dermal Filler Market Share Comparison (2018)
Daewoong Pharmaceuticals Key Product Pipeline
Shanghai Haohai Segment Overview
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017